OBJECTIVE: Changes in the plasma aldosterone concentration (PAC) and the plasma renin activity (PRA) have not been extensively studied in women with twin pregnancies.
Introduction
Twin pregnancy differs considerably from singleton pregnancy in many aspects, such as the duration of pregnancy [11] , the degree of enhancement of coagulation-fibrinolysis [14] , the prevalence of pregnancy-induced hypertension [13, 9] , and the degree of blood volume expansion [15] . All these data suggest that pregnancy-induced changes in various biological and physiological parameters may be greater in women with twin pregnancies than in women with singleton pregnancies.
In normal singleton pregnancies, the serum and urinary aldosterone levels are increased, reaching a maximum during the third trimester [2, 10] . The plasma renin activity (PRA) is also increased during pregnancy, reportedly reaching a maximum at different stages of pregnancy partially because of differences in assay methods [10] :
either at the end of the first trimester, followed by a sustained high level [7, 10] , or during the third trimester [2] . However, reductions in the plasma aldosterone concentration (PAC) and PRA occur temporally close to the clinical manifestation of preeclampsia in women with this condition [2, 3, 10] .
As blood parameters such as the platelet count and antithrombin activity are likely to decrease [12, 17] and creatinine, urate and aspartate aminotransferases are likely to increase before the development of hypertension in women with twin pregnancies [13] , the changes in PAC and PRA may differ between women with twin and singleton pregnancies. Accordingly, we conducted this prospective study.
Methods
This study was conducted prospectively after being approved by the institutional review board at Hokkaido University Hospital. A total of 101 women, consisting of 14 women with twin pregnancies and 87 women with singleton pregnancies, provided their written informed consent to participate in this study and gave birth during the 24-month period between October 2008 and September 2010 at Hokkaido University Hospital. All the participants donated 10 mL of blood during the second (23 to 27 weeks) and/or third (30 to 37 weeks) trimesters and on postpartum day 3 to determine the plasma aldosterone concentration (PAC) and plasma renin activity (PRA). Of the 14 women with twin pregnancies, none developed hypertension (systolic blood pressure ≥ 140 mmHg or diastolic blood pressure ≥ 90 mmHg) or proteinuria (≥ 0.3 g/day) while pregnant, but 7 of them transiently developed hypertension postpartum. All 87 women with singleton pregnancies were normotensive (systolic blood pressure < 140 mmHg and diastolic blood pressure < 90 mmHg) before 20 weeks of gestation, but two women became hypertensive just before the first blood sampling during the second trimester and three and two other women developed hypertension before and after the second blood sampling performed during the third trimester, respectively. These seven women who developed hypertension and proteinuria during pregnancy were classified as hypertensive women with singleton pregnancies. The remaining 80 women were normotensive throughout pregnancy and the postpartum period (normal control women group).
All the women were allowed an unrestrained sodium diet. Venous blood was drawn into ethylenediamine tetraacetic acid (EDTA) Vacutainer tubes while the participants were in a seated position after they had been ambulatory. The plasma samples were processed at room temperature to avoid the cryoactivation of prorenin, and the samples were stored at -40C until assayed. PRA was measured using a well-established radioimmunoassay kit (PRA [SRL]; Special Reference Laboratory Co., Tokyo) according to the manufacturer's instructions. PAC was measured using a radioimmunoassay kit (Spac-S aldosterone; Dai-ichi Radioimmunoassay Laboratory Co., Tokyo) according to the manufacturer's instructions. Intra-and inter-assay coefficient variations were less than 11.0% for PRA and were less than 7.0% for PAC.
Statistical analyses were performed using the JMP8 statistical software package (SAS, Cary, NC). Differences in the means were tested using the Tukey-Kramer HSD (honestly significant difference) test between each group, and categorical variables were compared using the Fisher exact test. A P value of less than 0.05 was considered to indicate statistical significance.
Results
No statistically significant differences were seen in maternal age, pre-pregnancy body mass index, or body mass index between the three groups ( Table 1 ). As two of the seven women with hypertensive singleton pregnancies gave birth at 24 and 25 weeks of gestation after the first blood sampling because of the worsening of preeclampsia and 3 of the 14 women with twin pregnancies gave birth before 30 weeks for reasons other than hypertensive disorders, the duration of pregnancy in these two groups was significantly shorter than that in women with normotensive singleton pregnancies.
In women with twin pregnancies, the mean PAC (pg/mL) of 598 ± 248 during the second trimester, which was significantly higher than that (421 ± 207) in women with normotensive singleton pregnancies ( Table 2 and Fig. 1 ), decreased significantly to 396 ± 210 during the third trimester, while that of 421 ± 207 in women with normotensive singleton pregnancies increased significantly to 667 ± 371, leading to a reversal of the PAC values between women with normotensive singleton pregnancies and those with twin pregnancies. In women with singleton pregnancies, the PAC was significantly lower in hypertensive women than in normotensive women during the third trimester.
Nine out of 11 (82%) women with twin pregnancies and three out of four (75%) women with hypertensive singleton pregnancies who were examined longitudinally exhibited a decrease in PAC, while a significantly smaller percentage (21% [14/66], p=0.0005 vs.
twin pregnancy) of women with normotensive singleton pregnancies exhibited a decrease in PAC (Fig. 1) . The PAC decreased significantly on postpartum day 3 in all three groups.
In women with twin pregnancies, the mean PRA (ng/mL/hour) of 10.0 ± 4.7 during the second trimester, which was significantly higher than that (7.3 ± 3.4) in women with normotensive singleton pregnancies ( Table 2 and Fig. 2 ), decreased significantly to 3.5 ± 2.9 during the third trimester and was significantly lower that that (6.9 ± 4.2) in women with normotensive singleton pregnancies and comparable to that (2.3 ± 1.6) in women with hypertensive singleton pregnancies. In women with singleton pregnancies, the PRA was significantly lower in hypertensive women than in normotensive women during the second and third trimesters. All 10 (100%) women with twin pregnancies and four (100%) hypertensive women with singleton pregnancies who were examined longitudinally exhibited a decrease in PRA, while a significantly smaller percentage (57% [32/66], p=0.0208 vs. twin pregnancy) of women with normotensive singleton pregnancies did so (Fig. 2) . The PRA decreased significantly on postpartum day 3 in all three groups.
The PAC-to-PRA ratio increased significantly with advancing gestation in both women with normotensive singleton pregnancies and those with twin pregnancies (Table 2 and Fig. 3) .
Discussion
This study demonstrated that both the PAC and PRA levels in women with twin pregnancies were significantly enhanced during the second trimester but significantly reduced during the third trimester, compared with those in normotensive women with singleton pregnancies. Reduced PAC and PRA levels were also confirmed in hypertensive women with singleton pregnancies, consistent with previous results [2, 3, 10] .
During normal pregnancy, the renin-angiotensin-aldosterone system is thought to play a vitally important role in salt balance. Preeclampsia is thought to occur as a result of a derangement in this delicate equilibrium [8] , although the precise mechanisms leading to the development of preeclampsia remain unknown. For example, PRA is suppressed in women with preeclampsia compared with that in normotensive pregnant women [2, 3, 10] , as was also shown in this study, and a longitudinal study demonstrated that a low PRA of < 4.0 ng/mL/hour at 20 weeks of gestation can predict the development of superimposed preeclampsia among women with chronic hypertension [1] . Thus, a reduced PRA is consistently associated with the development of hypertensive disorders in pregnancy.
Escher and Mohaupt [5] insisted that "As high aldosterone levels are required during normal pregnancy to increase the circulating plasma volume as an adaptative mechanism to support placental perfusion, a diminished aldosterone production attributed to genetic predisposition or exogenous factors would abrogate the pregnancy-associated expansion of circulating fluid volume in preeclampsia." The circulating blood volume is markedly reduced in women with preeclampsia and eclampsia [16, 19] , and this phenomenon may be explained partly by insufficient aldosterone production [5] based on the following findings: 1) serum and urinary aldosterone is suppressed in women with preeclampsia [2] [3] [4] 10] , as was also shown in this study; 2) urinary aldosterone (tetrahydro-aldosterone) is inversely correlated with blood pressure during pregnancy [4] ; and 3) supplemental NaCl administration during pregnancy was useful for reducing the blood pressure to within a normal range in a woman with a genetic predisposition to insufficient aldosterone production [6] , suggesting that a sufficient and adequate blood volume determined primarily by the PAC prevents the development of preeclampsia. Thus, the suppression of PAC, compared with that in normotensive women, is a characteristic feature of women who develop preeclampsia and may be responsible for the development of preeclampsia.
In this study, women with twin pregnancies exhibited enhanced PAC and PRA levels during the second trimester and reduced PAC and PRA levels during the third trimester. To the best of our knowledge, no previous reports have dealt with this issue in women with twin pregnancies. The normal maternal blood volume expansion is greater in women with twin pregnancies than in those with singleton pregnancies [15] .
According to the theory proposed by Escher and Mohaupt [5] , women with twin pregnancies require a higher PAC than women with singleton pregnancies. The higher PAC during the second trimester seen in the women with twin pregnancies may reflect the above situation. Women with twin pregnancies are more likely to develop hypertensive disorders, such as gestational hypertension, preeclampsia, and eclampsia, than women with singleton pregnancies [9, 13] . Although the present 14 women with twin pregnancies did not develop hypertension during pregnancy, seven (50.0%) of the 14 women developed hypertension postpartum, consistent with the results of a recent study in which 60 (40%) of 150 women with twin pregnancies developed postpartum hypertension [13] . Thus, women with twin pregnancies are prone to the development of hypertension. The significant decreases in PAC and PRA seen in women with twin pregnancies, resembling those reported in women with preeclampsia [2, 3, 10] , maybe responsible for the likelihood of hypertension in women with twin pregnancies.
Although not confirmed in this study (Table 2) , the PAC-to-PRA ratio is reportedly higher in women with preeclampsia than in normotensive women because of the relatively smaller decrease in PAC than in PRA in women with preeclampsia [3] .
Although the difference did not reach a significant level, the PAC-to-PRA ratio of the women with twin pregnancies appeared to be higher than that of normotensive women with singleton pregnancies and resembled that of hypertensive women with singleton pregnancies. Of the 10 women with twin pregnancies who were examined for both PAC and PRA longitudinally, 7 women developed postpartum hypertension and 3 did not. In the sub-analysis of these 10 women, the 7 women with postpartum hypertension exhibited PAC-to-PRA ratios of 69.4 ± 29.2 and 188.5 ± 172.2 pg/ml per ng/ml/hour during second and third trimester, respectively, while corresponding those were 56.8 ± 22.5 and 106.0 ± 47.3 pg/ml per ng/ml/hour in the 3 women without postpartum hypertension. Thus, a large increase in the PAC-to-PRA ratio appeared to precede the development of postpartum hypertension in the 7 women. A high PAC-to-PRA ratio ≥ 200 pg/ml per ng/ml/hour is known to occur in patients with primary aldosteronism [18] .
However, the mechanisms producing a higher PAC-to-PRA ratio in women with preeclampsia are poorly understood [3] .
In conclusion, a higher PAC and a higher PRA during the second trimester of women with twin pregnancies decreased sharply during the third trimester in the absence of hypertension. These changes in PAC and PRA differed considerably from those in normotensive women with singleton pregnancies but resembled those in hypertensive women with singleton pregnancies. Gesta5onal week (pg/ml per ng/ml/hour) n=14 n=7 n=80
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